Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction. The Importance of Thrombus Burden

Journal of the American College of Cardiology

Volumn 50, Issue 7, 2007, Pages 573-583

  Sianos, Georgios ^a   Papafaklis, Michail I ^a   Daemen, Joost ^a   Vaina, Sofia ^a   van Mieghem, Carlos A ^a   van Domburg, Ron T ^a   Michalis, Lampros K ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RHEOLYTIC THROMBECTOMY; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; STENT; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 34547591304     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.04.059     Document Type: Article

References (54)

1. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
2. Boersma E. Does time matter?. A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 (2006) 779-788
3. Saia F., Lemos P.A., Lee C.H., et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Circulation 108 (2003) 1927-1929
4. Lemos P.A., Saia F., Hofma S.H., et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared with conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 43 (2004) 704-708
5. Weber F., Schneider H., Schwarz C., Holzhausen C., Petzsch M., and Nienaber C.A. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction. Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions. Z Kardiol 93 (2004) 938-943
6. Valgimigli M., Percoco G., Malagutti P., et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 293 (2005) 2109-2117
7. Cheneau E., Rha S.W., Kuchulakanti P.K., et al. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc Interv 65 (2005) 469-472
8. Tanimoto S., Tsuchida K., Daemen J., and Boersma E. Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial? (TYPHOON, PASSION and HORIZONS trials). EuroInterv 2 (2006) 23-27
9. Menichelli M. Sirolimus stent versus bare stent in acute myocardial infarction trial (2006) Presented at: European Percutaneous Coronary Revascularization 2006 Course. Paris, France.
10. Spaulding C., Henry P., Teiger E., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
11. Margheri M., Giglioli C., Comeglio M., et al. Early outcome after paclitaxel-eluting stents in patients with acute and subacute myocardial infarction. A clinical study. Ital Heart J 5 (2004) 536-540
12. Hofma S.H., Ong A.T., Aoki J., et al. One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart 91 (2005) 1176-1180
13. Laarman G.J., Suttorp M.J., Dirksen M.T., et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
14. Honda Y., and Fitzgerald P.J. Stent thrombosis: an issue revisited in a changing world. Circulation 108 (2003) 2-5
15. Tolleson T.R., Newby L.K., Harrington R.A., et al. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol 92 (2003) 330-333
16. Alfonso F., Suarez A., Angiolillo D.J., et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 90 (2004) 1455-1459
17. Wenaweser P., Rey C., Eberli F.R., et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 26 (2005) 1180-1187
18. Ong A.T., Hoye A., Aoki J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
19. Urban P., Gershlick A.H., Guagliumi G., et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
20. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
21. Singh M., Berger P.B., Ting H.H., et al. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). Am J Cardiol 88 (2001) 1091-1096
22. White C.J., Ramee S.R., Collins T.J., et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation 93 (1996) 253-258
23. Stone G.W., Webb J., Cox D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
24. Ali A., Cox D., Dib N., et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 48 (2006) 244-252
25. Gibson C.M., de Lemos J.A., Murphy S.A., et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103 (2001) 2550-2554
26. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
27. van 't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F., and Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
28. Leon M.B., Baim D.S., Popma J.J., et al., Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
29. Mak K.H., Belli G., Ellis S.G., and Moliterno D.J. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 27 (1996) 494-503
30. Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
31. Harrington R.A., and Califf R.M. Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?. J Am Coll Cardiol 48 (2006) 2592-2595
32. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
33. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
34. Lemos P.A., Serruys P.W., van Domburg R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
35. Daemen J., Tanimoto S., Garcia-Garcia H.M., et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99 (2007) 1027-1032
36. Cheneau E., Leborgne L., Mintz G.S., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
37. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
38. Moussa I., Di Mario C., Reimers B., Akiyama T., Tobis J., and Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29 (1997) 6-12
39. Uren N.G., Schwarzacher S.P., Metz J.A., et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 23 (2002) 124-132
40. Fujii K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
41. Hong M.K., Mintz G.S., Lee C.W., et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 109 (2004) 881-886
42. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
43. Kernis S.J., Harjai K.J., Stone G.W., et al. The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1173-1177
44. Borna C., Lazarowski E., van Heusden C., Ohlin H., and Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3 (2005) 10
45. Wenaweser P., Dorffler-Melly J., Imboden K., et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752
46. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
47. Parodi G., Valenti R., Carrabba N., et al. Long-term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 68 (2006) 50-55
48. Antoniucci D., Valenti R., Migliorini A., et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 93 (2004) 1033-1035
49. Napodano M., Pasquetto G., Sacca S., et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1395-1402
50. De Luca L., Sardella G., Davidson C.J., et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodeling in patients with anterior ST elevation myocardial infarction. Heart 92 (2006) 951-957
51. Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
52. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
53. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) 671-719
54. Hwang C.W., Levin A.D., Jonas M., Li P.H., and Edelman E.R. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 111 (2005) 1619-1626